Being a potential potent inhibitor of LRRK2 kinase activity with low risk for off-target side effects, Vit B12 supplementation in patients with PD (PwPD) seems appealing and encourages future clinical trials to investigate this potent effect as such evidence remains restrained to animal models (Green and Christine 2019) (Fig
blendsOut of Stock WOLVERINE (BPC-157 5mg / TB-500 5mg) 10mg blend Purity: 99% (individual components) Price unavailable WOLVERINE is a dual-peptide research blend combining BPC-157 5mg and TB-500 5mg for in vitro studies examining cytoskeletal dynamics and cellular signaling interactions
To load the syringe, follow these steps: Remove the needle cap from the syringe and set it aside
Long-term safety Research status : Limited long-term human studies (newer peptides) Available data : Animal studies show excellent safety Human case reports very positive No known serious adverse effects Mitochondrial support theoretically beneficial Precautionary approach : Start with lower doses Monitor how you feel Consider periodic breaks Track health markers Contraindications Avoid if : Pregnancy or breastfeeding (no safety data) Active cancer (theoretical mitochondrial support to cancer cells) Severe cardiovascular disease (consult doctor) Consult doctor if : Chronic health conditions Taking multiple medications Mitochondrial disorders (ironically, may need medical supervision) Monitoring Recommended blood work : Baseline metabolic panel Glucose/HbA1c (if using for metabolic health) Liver/kidney function Retest at 12 weeks Frequency : Every 3-6 months during long-term use Biomarkers to track : Fasting glucose Insulin sensitivity markers Inflammatory markers (hs-CRP) Energy levels (subjective) Sourcing quality NAD+ peptides Quality critical for effectiveness and safety
Regarding the SEV group, the results indicate that in addition to suppressing viral infection, B12 induces inflammatory attenuation during severe COVID-19 and promotes activation of the adaptive immune response
